These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sustained release of erythropoietin using biodegradable gelatin hydrogel microspheres persistently improves lower leg ischemia. Li L; Okada H; Takemura G; Esaki M; Kobayashi H; Kanamori H; Kawamura I; Maruyama R; Fujiwara T; Fujiwara H; Tabata Y; Minatoguchi S J Am Coll Cardiol; 2009 Jun; 53(25):2378-88. PubMed ID: 19539150 [TBL] [Abstract][Full Text] [Related]
3. [Therapeutic effects and related mechanisms of erythropoietin sustained-release gelatin hydrogel microspheres on a murine model of hindlimb ischemia]. Xiao JW; Li LH; Hong BZ; Xiao JQ; Wei DM; Jin Z Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jun; 44(6):524-9. PubMed ID: 27346267 [TBL] [Abstract][Full Text] [Related]
4. Co-delivery of FGF-2 and G-CSF from gelatin-based hydrogels as angiogenic therapy in a murine critical limb ischemic model. Layman H; Sacasa M; Murphy AE; Murphy AM; Pham SM; Andreopoulos FM Acta Biomater; 2009 Jan; 5(1):230-9. PubMed ID: 18713669 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor. Lee M; Aoki M; Kondo T; Kobayashi K; Okumura K; Komori K; Murohara T Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2535-41. PubMed ID: 16224058 [TBL] [Abstract][Full Text] [Related]
6. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels. Matsui M; Tabata Y Acta Biomater; 2012 May; 8(5):1792-801. PubMed ID: 22293581 [TBL] [Abstract][Full Text] [Related]
7. Granulocyte colony-stimulating factor facilitates the angiogenesis induced by ultrasonic microbubble destruction. Miyake Y; Ohmori K; Yoshida J; Ishizawa M; Mizukawa M; Yukiiri K; Kohno M Ultrasound Med Biol; 2007 Nov; 33(11):1796-804. PubMed ID: 17686568 [TBL] [Abstract][Full Text] [Related]
8. Enhanced vascularization by controlled release of platelet-rich plasma impregnated in biodegradable gelatin hydrogel. Kurita J; Miyamoto M; Ishii Y; Aoyama J; Takagi G; Naito Z; Tabata Y; Ochi M; Shimizu K Ann Thorac Surg; 2011 Sep; 92(3):837-44; discussion 844. PubMed ID: 21871267 [TBL] [Abstract][Full Text] [Related]
9. Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres. Layman H; Li X; Nagar E; Vial X; Pham SM; Andreopoulos FM J Biomater Sci Polym Ed; 2012; 23(1-4):185-206. PubMed ID: 21192837 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb. Zhang H; Zhang N; Li M; Feng H; Jin W; Zhao H; Chen X; Tian L Ann Vasc Surg; 2008 Mar; 22(2):238-47. PubMed ID: 18083329 [TBL] [Abstract][Full Text] [Related]
11. G-CSF and HGF: combination of vasculogenesis and angiogenesis synergistically improves recovery in murine hind limb ischemia. Ieda Y; Fujita J; Ieda M; Yagi T; Kawada H; Ando K; Fukuda K J Mol Cell Cardiol; 2007 Mar; 42(3):540-8. PubMed ID: 17223129 [TBL] [Abstract][Full Text] [Related]
12. Synergistic angiogenic effect of codelivering fibroblast growth factor 2 and granulocyte-colony stimulating factor from fibrin scaffolds and bone marrow transplantation in critical limb ischemia. Layman H; Rahnemai-Azar AA; Pham SM; Tsechpenakis G; Andreopoulos FM Tissue Eng Part A; 2011 Jan; 17(1-2):243-54. PubMed ID: 20712534 [TBL] [Abstract][Full Text] [Related]
13. Combined sustained delivery of basic fibroblast growth factor and administration of granulocyte colony-stimulating factor: synergistic effect on angiogenesis in mouse ischemic limbs. Jeon O; Hwang KC; Yoo KJ; Kim BS J Endovasc Ther; 2006 Apr; 13(2):175-81. PubMed ID: 16643071 [TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling. Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976 [TBL] [Abstract][Full Text] [Related]
15. Co-delivery of G-CSF and EPO released from fibrin gel for therapeutic neovascularization in rat hindlimb ischemia model. Chen F; Liu Q; Zhang ZD; Zhu XH Microcirculation; 2013 Jul; 20(5):416-24. PubMed ID: 23294128 [TBL] [Abstract][Full Text] [Related]
16. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease. Honold J; Lehmann R; Heeschen C; Walter DH; Assmus B; Sasaki K; Martin H; Haendeler J; Zeiher AM; Dimmeler S Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2238-43. PubMed ID: 16902165 [TBL] [Abstract][Full Text] [Related]
17. Gelatin hydrogel microspheres enable pinpoint delivery of basic fibroblast growth factor for the development of functional collateral vessels. Hosaka A; Koyama H; Kushibiki T; Tabata Y; Nishiyama N; Miyata T; Shigematsu H; Takato T; Nagawa H Circulation; 2004 Nov; 110(21):3322-8. PubMed ID: 15520306 [TBL] [Abstract][Full Text] [Related]
18. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice. Qi X; Okamoto Y; Murakawa T; Wang F; Oyama O; Ohkawa R; Yoshioka K; Du W; Sugimoto N; Yatomi Y; Takuwa N; Takuwa Y Eur J Pharmacol; 2010 May; 634(1-3):121-31. PubMed ID: 20206620 [TBL] [Abstract][Full Text] [Related]
19. G-CSF and/or M-CSF accelerate differentiation of bone marrow cells into endothelial progenitor cells in vitro. Zhang Y; Adachi Y; Iwasaki M; Minamino K; Suzuki Y; Nakano K; Koike Y; Mukaide H; Shigematsu A; Kiriyama N; Li C; Ikehara S Oncol Rep; 2006 Jun; 15(6):1523-7. PubMed ID: 16685390 [TBL] [Abstract][Full Text] [Related]